Effective Combination of Innate and Adaptive Immunotherapeutic Approaches in a Mouse Melanoma Model.

about

Is immunity in cancer the key to improving clinical outcome?: Report on the International Symposium on Immunotherapy, The Royal Society, London, UK, 12-13 May 2017.Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.

P2860

Q42336210-497929B3-8A84-4DD6-975D-06A58FF98F37 Q46721978-CEBE8401-DF8B-4E8A-9663-A3B497B45AB9

P2860

Effective Combination of Innate and Adaptive Immunotherapeutic Approaches in a Mouse Melanoma Model.

Item

http://www.wikidata.org/entity/Q48375822

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Effective Combination of Innat ...... hes in a Mouse Melanoma Model.

@en

Effective Combination of Innat ...... hes in a Mouse Melanoma Model.

@nl

type

Item

label

Effective Combination of Innat ...... hes in a Mouse Melanoma Model.

@en

Effective Combination of Innat ...... hes in a Mouse Melanoma Model.

@nl

prefLabel

Effective Combination of Innat ...... hes in a Mouse Melanoma Model.

@en

Effective Combination of Innat ...... hes in a Mouse Melanoma Model.

@nl

P1476

Effective Combination of Innat ...... hes in a Mouse Melanoma Model.

@en

P2093

Alexander L Rakhmilevich

http://www.w3.org/2001/XMLSchema#string

Anna Hoefges

http://www.w3.org/2001/XMLSchema#string

Hans Loibner

http://www.w3.org/2001/XMLSchema#string

Kayla Rasmussen

http://www.w3.org/2001/XMLSchema#string

Mildred Felder

http://www.w3.org/2001/XMLSchema#string

Paul M Sondel

http://www.w3.org/2001/XMLSchema#string

P2860

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

Adoptive immunotherapy for acute leukemia: New insights in chimeric antigen receptors

CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients.

Improving natural killer cell cancer immunotherapy

Immune checkpoint proteins: a new therapeutic paradigm for cancer--preclinical background: CTLA-4 and PD-1 blockade

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

Nanoparticle-delivered multimeric soluble CD40L DNA combined with Toll-Like Receptor agonists as a treatment for melanoma.

Rational combinations of immunotherapeutics that target discrete pathways.

Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape

Cryotherapy with concurrent CpG oligonucleotide treatment controls local tumor recurrence and modulates HER2/neu immunity.

P304

1575-1584

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1601255

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

198

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28062694

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

5296279

http://www.w3.org/2001/XMLSchema#string

Effective Combination of Innate and Adaptive Immunotherapeutic Approaches in a Mouse Melanoma Model.

about

P2860

P2860

Effective Combination of Innate and Adaptive Immunotherapeutic Approaches in a Mouse Melanoma Model.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932